Direkt zum Inhalt
Merck

Fortfahren mit

BP700

Oxybuprocain -hydrochlorid

British Pharmacopoeia (BP) Reference Standard

Synonym(e):

Benoxinat -hydrochlorid, 4-Amino-3-butoxybenzoesäure-[2-(diethylamino)-ethyl]-ester -hydrochlorid, Oxybuprocain -hydrochlorid

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

Ansicht ändern
PackungsgrößeSKUVerfügbarkeitPreis

Über diesen Artikel

Empirische Formel (Hill-System):
C17H28N2O3 · HCl
CAS-Nummer:
Molekulargewicht:
344.88
UNSPSC Code:
41116107
NACRES:
NA.24
MDL number:
Preise und Verfügbarkeit sind derzeit nicht verfügbar.
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhalten


grade

pharmaceutical primary standard

API family

oxybuprocaine

form

solid

shelf life

limited shelf life, expiry date on the label

manufacturer/tradename

BP

application(s)

pharmaceutical
pharmaceutical small molecule

format

neat

storage temp.

2-8°C

SMILES string

Cl[H].CCCCOc1cc(ccc1N)C(=O)OCCN(CC)CC

InChI

1S/C17H28N2O3.ClH/c1-4-7-11-21-16-13-14(8-9-15(16)18)17(20)22-12-10-19(5-2)6-3;/h8-9,13H,4-7,10-12,18H2,1-3H3;1H

InChI key

PRGUDWLMFLCODA-UHFFFAOYSA-N

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Oxybuprocaine hydrochloride BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:
  • Oxybuprocaine Eye Drops
  • Packaging

    Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

    Other Notes

    Sales restrictions may apply.

    Ähnliche Artikel vergleichen

    Vollständigen Vergleich anzeigen

    Unterschiede anzeigen

    1 of 1

    Dieser Artikel
    O02700001050009B9050
    manufacturer/tradename

    BP

    manufacturer/tradename

    EDQM

    manufacturer/tradename

    USP

    manufacturer/tradename

    -

    grade

    pharmaceutical primary standard

    grade

    pharmaceutical primary standard

    grade

    pharmaceutical primary standard

    grade

    -

    form

    solid

    form

    -

    form

    -

    form

    solid

    application(s)

    pharmaceutical
    pharmaceutical small molecule

    application(s)

    pharmaceutical (small molecule)

    application(s)

    pharmaceutical (small molecule)

    application(s)

    pharmaceutical (small molecule)

    format

    neat

    format

    neat

    format

    neat

    format

    -

    shelf life

    limited shelf life, expiry date on the label

    shelf life

    -

    shelf life

    -

    shelf life

    -


    Still not finding the right product?

    Explore all of our products under Oxybuprocain -hydrochlorid


    Lagerklasse

    11 - Combustible Solids

    wgk

    WGK 3

    flash_point_f

    Not applicable

    flash_point_c

    Not applicable



    Hier finden Sie alle aktuellen Versionen:

    Analysenzertifikate (COA)

    Lot/Batch Number

    It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumente section.

    Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

    Besitzen Sie dieses Produkt bereits?

    In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

    Die Dokumentenbibliothek aufrufen



    Maurizio Cammalleri et al.
    Frontiers in pharmacology, 12, 671238-671238 (2021-06-25)
    Neuropathic ocular pain is a frequent occurrence in medium to severe dry eye disease (DED). Only palliative treatments, such as lubricants and anti-inflammatory drugs, are available to alleviate patients' discomfort. Anesthetic drugs are not indicated, because they may interfere with



    Questions

    Reviews

    No rating value

    Active Filters